Literature DB >> 18384919

Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine.

Haroldo Toro1, De-chu C Tang, David L Suarez, Jianfeng Zhang, Zhongkai Shi.   

Abstract

Protective immunity against avian influenza (AI) virus was elicited in chickens by single-dose vaccination with a replication competent adenovirus (RCA)-free human adenovirus (Ad) vector encoding an H7 AI hemagglutinin (AdChNY94.H7). Chickens vaccinated in ovo with an Ad vector encoding an AI H5 (AdTW68.H5) previously described, which were subsequently vaccinated intramuscularly with AdChNY94.H7 post-hatch, responded with robust antibody titers against both the H5 and H7 AI proteins. Antibody responses to Ad vector in ovo vaccination follow a dose-response kinetic. The use of a synthetic AI H5 gene codon optimized to match the chicken cell tRNA pool was more potent than the cognate H5 gene. The use of Ad-vectored vaccines to increase resistance of chicken populations against multiple AI strains could reduce the risk of an avian-originating influenza pandemic in humans.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18384919      PMCID： PMC2720404          DOI： 10.1016/j.vaccine.2008.02.056

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  19 in total

1.  Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert.

Authors:  D E Swayne; M Garcia; J R Beck; N Kinney; D L Suarez
Journal:  Vaccine       Date:  2000-01-06       Impact factor: 3.641

2.  Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza.

Authors:  Chang-Won Lee; Dennis A Senne; David L Suarez
Journal:  Vaccine       Date:  2004-08-13       Impact factor: 3.641

3.  Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines.

Authors:  Z Shi; M Zeng; G Yang; F Siegel; L J Cain; K R van Kampen; C A Elmets; D C Tang
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 4.  Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control.

Authors:  Maurice R Hilleman
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

5.  Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes.

Authors:  Erica Spackman; Dennis A Senne; T J Myers; Leslie L Bulaga; Lindsey P Garber; Michael L Perdue; Kenton Lohman; Luke T Daum; David L Suarez
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

6.  Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector.

Authors:  Yongping Jiang; Kangzhen Yu; Hongbo Zhang; Pingjing Zhang; Chenjun Li; Guobin Tian; Yanbing Li; Xijun Wang; Jinying Ge; Zhigao Bu; Hualan Chen
Journal:  Antiviral Res       Date:  2007-04-09       Impact factor: 5.970

7.  Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells.

Authors:  Nina Mossadegh; Lutz Gissmann; Martin Müller; Hanswalter Zentgraf; Angel Alonso; Pascal Tomakidi
Journal:  Virology       Date:  2004-08-15       Impact factor: 3.616

8.  Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.

Authors:  Lakshmi Ramakrishna; Krishnamurthy Kumar Anand; Kumarasamypet M Mohankumar; Udaykumar Ranga
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Effect of in ovo vaccine delivery route on herpesvirus of turkeys/SB-1 efficacy and viremia.

Authors:  Patricia S Wakenell; Thomas Bryan; Jon Schaeffer; Alan Avakian; Chris Williams; Craig Whitfill
Journal:  Avian Dis       Date:  2002 Apr-Jun       Impact factor: 1.577

10.  Recombination resulting in virulence shift in avian influenza outbreak, Chile.

Authors:  David L Suarez; Dennis A Senne; Jill Banks; Ian H Brown; Steve C Essen; Chang-Won Lee; Ruth J Manvell; Christian Mathieu-Benson; Valentina Moreno; Janice C Pedersen; Brundaban Panigrahy; Hernán Rojas; Erica Spackman; Dennis J Alexander
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883
View more
  16 in total

1.  Avian influenza vaccination in chickens and pigs with replication-competent adenovirus-free human recombinant adenovirus 5.

Authors:  Haroldo Toro; Frederik W van Ginkel; De-Chu C Tang; Bettina Schemera; Soren Rodning; Joseph Newton
Journal:  Avian Dis       Date:  2010-03       Impact factor: 1.577

Review 2.  Development of adenoviral vector-based mucosal vaccine against influenza.

Authors:  Irina L Tutykhina; Denis Y Logunov; Dmitriy N Shcherbinin; Maxim M Shmarov; Amir I Tukhvatulin; Boris S Naroditsky; Alexander L Gintsburg
Journal:  J Mol Med (Berl)       Date:  2010-11-21       Impact factor: 4.599

3.  Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes.

Authors:  Shailbala Singh; Haroldo Toro; De-Chu Tang; Worthie E Briles; Linda M Yates; Renee T Kopulos; Ellen W Collisson
Journal:  Virology       Date:  2010-06-16       Impact factor: 3.616

Review 4.  Production of adenovirus vectors and their use as a delivery system for influenza vaccines.

Authors:  Sai V Vemula; Suresh K Mittal
Journal:  Expert Opin Biol Ther       Date:  2010-10       Impact factor: 4.388

5.  Development of avian influenza virus H5 DNA vaccine and MDP-1 gene of Mycobacterium bovis as genetic adjuvant.

Authors:  Babak Jalilian; Abdul Rahman Omar; Mohd Hair Bejo; Noorjahan Banu Alitheen; Mehdi Rasoli; Sohkichi Matsumoto
Journal:  Genet Vaccines Ther       Date:  2010-05-24

6.  The prevention and control of avian influenza: the avian influenza coordinated agriculture project.

Authors:  C Cardona; R Slemons; D Perez
Journal:  Poult Sci       Date:  2009-04       Impact factor: 3.352

Review 7.  Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines.

Authors:  De-chu C Tang; Jianfeng Zhang; Haroldo Toro; Zhongkai Shi; Kent R Van Kampen
Journal:  Expert Rev Vaccines       Date:  2009-04       Impact factor: 5.217

8.  Induction of mucosal immunity in the avian Harderian gland with a replication-deficient Ad5 vector expressing avian influenza H5 hemagglutinin.

Authors:  Frederik W van Ginkel; De-chu C Tang; Stephen L Gulley; Haroldo Toro
Journal:  Dev Comp Immunol       Date:  2009       Impact factor: 3.636

9.  A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

Authors:  Kawsar R Talaat; Ruth A Karron; Karen A Callahan; Catherine J Luke; Susan C DiLorenzo; Grace L Chen; Elaine W Lamirande; Hong Jin; Kathy L Coelingh; Brian R Murphy; George Kemble; Kanta Subbarao
Journal:  Vaccine       Date:  2009-04-17       Impact factor: 3.641

10.  Improved efficacy of a gene optimised adenovirus-based vaccine for venezuelan equine encephalitis virus.

Authors:  Amanda J Williams; Lyn M O'Brien; Robert J Phillpotts; Stuart D Perkins
Journal:  Virol J       Date:  2009-07-31       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.